Literature DB >> 30023108

Weighing the relative importance of short-term versus long-term outcomes when comparing surgery versus stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer.

Paul J Speicher1, Thomas A D'Amico1.   

Abstract

Entities:  

Year:  2018        PMID： 30023108      PMCID： PMC6036009          DOI： 10.21037/jtd.2018.05.42

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  13 in total

1.  Cancer statistics, 2018.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-01-04       Impact factor: 508.702

2.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.

Authors:  R J Ginsberg; L V Rubinstein
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

3.  Stereotactic body radiotherapy using a radiobiology-based regimen for stage I non-small-cell lung cancer: five-year mature results.

Authors:  Yuta Shibamoto; Chisa Hashizume; Fumiya Baba; Shiho Ayakawa; Akifumi Miyakawa; Taro Murai; Taiki Takaoka; Yukiko Hattori; Ryuji Asai
Journal:  J Thorac Oncol       Date:  2015-06       Impact factor: 15.609

4.  Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.

Authors:  Frank J Lagerwaard; Naomi E Verstegen; Cornelis J A Haasbeek; Ben J Slotman; Marinus A Paul; Egbert F Smit; Suresh Senan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-11-19       Impact factor: 7.038

5.  Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline.

Authors:  Gregory M M Videtic; Jessica Donington; Meredith Giuliani; John Heinzerling; Tomer Z Karas; Chris R Kelsey; Brian E Lally; Karen Latzka; Simon S Lo; Drew Moghanaki; Benjamin Movsas; Andreas Rimner; Michael Roach; George Rodrigues; Shervin M Shirvani; Charles B Simone; Robert Timmerman; Megan E Daly
Journal:  Pract Radiat Oncol       Date:  2017-06-05

6.  Stage I Lung SBRT Clinical Practice Patterns.

Authors:  Christopher D Corso; Henry S Park; Amy C Moreno; Anthony W Kim; James B Yu; Zain A Husain; Roy H Decker
Journal:  Am J Clin Oncol       Date:  2017-08       Impact factor: 2.339

7.  Sublobar Resection for Clinical Stage IA Non-small-cell Lung Cancer in the United States.

Authors:  Paul J Speicher; Lin Gu; Brian C Gulack; Xiaofei Wang; Thomas A D'Amico; Matthew G Hartwig; Mark F Berry
Journal:  Clin Lung Cancer       Date:  2015-08-03       Impact factor: 4.785

8.  Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline.

Authors:  Bryan J Schneider; Megan E Daly; Erin B Kennedy; Mara B Antonoff; Stephen Broderick; Jill Feldman; Shruti Jolly; Bryan Meyers; Gaetano Rocco; Chad Rusthoven; Ben J Slotman; Daniel H Sterman; Brendon M Stiles
Journal:  J Clin Oncol       Date:  2017-11-06       Impact factor: 44.544

9.  Stereotactic body radiotherapy for operable early-stage non-small cell lung cancer.

Authors:  Takahisa Eriguchi; Atsuya Takeda; Naoko Sanuki; Yuichiro Tsurugai; Yousuke Aoki; Yohei Oku; Yu Hara; Takeshi Akiba; Naoyuki Shigematsu
Journal:  Lung Cancer       Date:  2017-05-04       Impact factor: 5.705

10.  Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403.

Authors:  Yasushi Nagata; Masahiro Hiraoka; Taro Shibata; Hiroshi Onishi; Masaki Kokubo; Katsuyuki Karasawa; Yoshiyuki Shioyama; Rikiya Onimaru; Takuyo Kozuka; Etsuo Kunieda; Tsutomu Saito; Keiichi Nakagawa; Masato Hareyama; Yoshihiro Takai; Kazushige Hayakawa; Norio Mitsuhashi; Satoshi Ishikura
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-11-11       Impact factor: 7.038
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.